$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis

International journal of obesity : journal of the International Association for the Study of Obesity, v.32 no.2, 2008년, pp.381 - 387  

Manco, M (1Liver Unit, Pathology Department, ‘Bambino Gesù) ,  Marcellini, M (’ Children's Hospital and Research Institute, Rome, Italy) ,  DeVito, R (1Liver Unit, Pathology Department, ‘Bambino Gesù) ,  Comparcola, D (’ Children's Hospital and Research Institute, Rome, Italy) ,  Sartorelli, M R (1Liver Unit, Pathology Department, ‘Bambino Gesù) ,  Nobili, V (’ Children's Hospital and Research Institute, Rome, Italy)

Abstract AI-Helper 아이콘AI-Helper

Objective:Our aim was to estimate prevalence of metabolic syndrome (MS), obesity and comorbidities in a cohort of 120 children (3–18 years) with biopsy-proven non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) and to evaluate correlations between clinical or bioc...

참고문헌 (30)

  1. 10.1001/jama.285.19.2486 Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. 

  2. N Engl J Med P Angulo 346 1221 2002 10.1056/NEJMra011775 Angulo P . Non-alcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231. 

  3. Diabetes G Marchesini 50 1844 2001 10.2337/diabetes.50.8.1844 Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850. 

  4. Metabolism SY Oh 55 1604 2006 10.1016/j.metabol.2006.07.021 Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006; 55: 1604-1609. 

  5. Diabetes AJ Hanley 54 3140 2005 10.2337/diabetes.54.11.3140 Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino Jr RB, Haffner SM . Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005; 54: 3140-3147. 

  6. Hepatology G Bedogni 42 44 2005 10.1002/hep.20734 Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S . Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52. 

  7. Am J Gastroenterol H Kang 101 2247 2006 10.1111/j.1572-0241.2006.00719.x Kang H, Greenson JK, Omo JT, Chao C, Peterman D, Anderson L et al. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol 2006; 101: 2247-2253. 

  8. Scand J Gastroenterol JW Haukeland 40 1469 2005 10.1080/00365520500264953 Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Loberg E, Haaland T et al. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2005; 40: 1469-1477. 

  9. Hepatology G Marchesini 37 917 2003 10.1053/jhep.2003.50161 Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923. 

  10. Hepatology GA Abrams 40 475 2004 10.1002/hep.20323 Abrams GA, Kunde SS, Lazenby AJ, Clements RH . Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease. Hepatology 2004; 40: 475-483. 

  11. Int J Obes Relat Metab Disord G Guzzaloni 24 772 2000 10.1038/sj.ijo.0801224 Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F . Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000; 24: 772-776. 

  12. Hepatology V Nobili 44 458 2006 10.1002/hep.21262 Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D et al. Nonalcoholic fatty liver disease in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006; 44: 458-465. 

  13. J Pediatr JR Schwimmer 143 500 2003 10.1067/S0022-3476(03)00325-1 Schwimmer JR, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE . Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003; 143: 500-505. 

  14. JH Himes 1991 Anthropometric Assessment of Nutritional Status Himes JH . Anthropometric Assessment of Nutritional Status. Wiley-Liss Inc.: New York, 1991. 

  15. BMJ TJ Cole 320 1 2000 10.1136/bmj.320.7244.1240 Cole TJ, Bellizzi MC, Flegal KM, Dietz WH . Establishing a standard definition for child overweight obesity worldwide: International survey. BMJ 2000; 320: 1-6. 

  16. Pediatrics CM Boney 115 e290 2005 10.1542/peds.2004-1808 Boney CM, Verma A, Tucker R, Vohr BR . Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290-e296. 

  17. 10.1542/peds.89.3.495 American Academy of Pediatrics, National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89: 525-584. 

  18. 10.1542/peds.79.1.1 Report of the second task force on blood pressure control in children-1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987; 79: 1-25. 

  19. Diabetes Care Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 20 1183 1997 10.2337/diacare.20.7.1183 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197. 

  20. Diabetologia DR Matthews 28 412 1985 10.1007/BF00280883 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. 

  21. J Clin Endocrinol Metab A Katz 85 2402 2000 10.1210/jcem.85.7.6661 Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410. 

  22. Diabetes Care M Matsuda 22 1462 1999 10.2337/diacare.22.9.1462 Matsuda M, De Fronzo RA . Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470. 

  23. Diabetes WJ Sluiter 25 241 1976 10.2337/diab.25.4.241 Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H . Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes 1976; 25: 241-244. 

  24. Diabet Med DI Phillips 11 286 1994 10.1111/j.1464-5491.1994.tb00273.x Phillips DI, Clark PM, Hales CN, Osmond C . Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994; 11: 286-292. 

  25. Hepatology DE Kleiner 41 1313 2005 10.1002/hep.20701 Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321. 

  26. J Searle 1987 Pathology of the Liver Searle J, Kerr JRF, Halliday JW . Iron storage disease. In: MacSwwen RNM, Anthony PP, Scheuer PJ (eds). Pathology of the Liver, 2nd edn. Churchill Livingstone: Edinburgh, 1987. 

  27. Hepatology JB Schwimmer 42 641 2005 10.1002/hep.20842 Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005; 42: 641-649. 

  28. Diabetes Care LS Conwell 27 314 2004 10.2337/diacare.27.2.314 Conwell LS, Trost SG, Brown WJ, Batch JA . Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004; 27: 314-319. 

  29. Arch Pediatr Adolesc Med S Cook 157 821 2003 10.1001/archpedi.157.8.821 Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH . Prevalence of the metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-827. 

  30. Diabetes SE Kahn 42 1663 1993 10.2337/diab.42.11.1663 Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672. 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로